DAVA Pharmaceuticals

Fort Lee, United States Founded: 2004 • Age: 22 yrs Acquired By Endo International
Generic drugs are manufactured and distributed by DAVA Pharmaceuticals.

About DAVA Pharmaceuticals

DAVA Pharmaceuticals is a Healthcare company based in Fort Lee (United States) founded in 2004, and was acquired by Endo International in June 2014. Generic drugs are manufactured and distributed by DAVA Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals.

Company details

DAVA Pharmaceuticals was founded in 2004 and is based in Fort Lee, United States. Operations are centered on the pharmaceutical sector, where generic drugs are produced to serve healthcare needs. Manufacturing activities are conducted to ensure compliance with industry standards, and the companys domain, davapharma.com, supports its digital operations. Focus remains on providing essential medications across domestic markets.

Key Metrics

Investors in DAVA Pharmaceuticals

DAVA Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Endo International.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Global pharmaceutical company manufacturing branded, generic formulations, and OTC medicines
1997endo.comMalvern, United States
Premium access

Investor details for DAVA Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of DAVA Pharmaceuticals

2 dated milestones of DAVA Pharmaceuticals across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded DAVA Pharmaceuticals is founded.
  2. Exit Acquired by Endo International.

Web traffic of DAVA Pharmaceuticals

Websites that share an audience with DAVA Pharmaceuticals (davapharma.com).

Similar websites

Websites whose visitors overlap most with DAVA Pharmaceuticals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
palmettopharm.com
100%
1.3K#11,520,260View details
nucarerx.com
nucarerx.com
99%
#10,661,435–

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as DAVA Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DAVA Pharmaceuticals

DAVA Pharmaceuticals was founded in 2004.

DAVA Pharmaceuticals is headquartered in Fort Lee, United States. It is registered at Fort Lee, New Jersey, United States.

DAVA Pharmaceuticals was founded in 2004 and is based in Fort Lee, United States. Operations are centered on the pharmaceutical sector, where generic drugs are produced to serve healthcare needs. Manufacturing activities are conducted to ensure compliance with industry standards, and the companys domain, davapharma.com, supports its digital operations. Focus remains on providing essential medications across domestic markets.

DAVA Pharmaceuticals has 1 investor. Key investors include Endo International.

Yes. DAVA Pharmaceuticals was acquired by Endo International in June 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available